Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.36 |
| ▸ | AR | P10275 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | NR1H2 | P55055 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.32 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5147311 | 0.94 | LMNA (0.37) | LMNAHTTUSP2PLA2G7AR | |
| SCHEMBL2976150 | 0.88 | LIMK1 (0.33) | USP2ALDH1A1LIMK1TSHR | |
| SCHEMBL5147498 | 0.88 | ALDH1A1 (0.36) | LMNAHTTPLA2G7ALDH1A1MAPK1 | |
| SCHEMBL5148410 | 0.84 | LMNA (0.39) | LMNAHTTUSP2PLA2G7AR | |
| SCHEMBL5146010 | 0.83 | POLB (0.35) | LMNAHTTUSP2ARALDH1A1 | |
| SCHEMBL5148335 | 0.82 | PDE3B (0.36) | LMNAHTTPLA2G7ALDH1A1MAPK1 | |
| SCHEMBL2971724 | 0.82 | PDE3B (0.35) | USP2ALDH1A1LIMK1 | |
| SCHEMBL5147280 | 0.77 | BRAF (0.37) | LMNAHTTALDH1A1MAPK1TSHR | |
| SCHEMBL2988460 | 0.76 | PDE3B (0.32) | USP2ALDH1A1TSHR | |
| SCHEMBL5147380 | 0.76 | ALDH1A1 (0.40) | LMNAHTTALDH1A1MAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1831207-A1 | AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE | Amgen Inc. (US) | 2007-09-12 | — | — | EP | disclosed |
| WO-2006066172-A1 | AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE | AMGEN, INC. (US) | 2006-06-22 | — | — | WO | disclosed |